Pharma Pass LLC
Records under this name other than patents Pharma Pass LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,531,153 | Composition with Sustained Release of Levodopa and Carbidopa Formerly held Term ended Term ended May 29, 2021 · High confidence | Term ended | Term ended May 29, 2021 | High confidence |
| US 6,338,857 | Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release Formerly held Term ended Term ended May 26, 2020 · USPTO record | Term ended | Term ended May 26, 2020 | USPTO record |
| US 6,143,327 | Delayed release coated tablet of bupropion hydrochloride Formerly held Term ended Term ended Dec 13, 2019 · USPTO record | Term ended | Term ended Dec 13, 2019 | USPTO record |
| US 6,033,686 | Controlled release tablet of bupropion hydrochloride Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,096,341 | Delayed release tablet of bupropion hydrochloride Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,159,499 | Composition containing an acid-labile benzimidazole and process for its preparation Formerly held Term ended Term ended Oct 20, 2018 · USPTO record | Term ended | Term ended Oct 20, 2018 | USPTO record |
| US 6,413,503 | Use of cyclic enamines as light protection agents Lapsed on the fee record Ended Jul 2, 2014 · USPTO record | Lapsed on the fee record | Ended Jul 2, 2014 | USPTO record |
| US 6,368,628 | Sustained release pharmaceutical composition free of food effect Formerly held Lapsed on the fee record Ended Apr 9, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 9, 2014 | USPTO record |
| US 6,348,469 | Solid compositions containing glipizide and polyethylene oxide Formerly held Lapsed on the fee record Ended Feb 19, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 19, 2014 | USPTO record |
| US 6,117,453 | Solid compositions containing polyethylene oxide and an active ingredient Formerly held Lapsed on the fee record Ended Sep 12, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | USPTO record |